Mark D Krailo

Mark D Krailo

UNVERIFIED PROFILE

Are you Mark D Krailo?   Register this Author

Register author
Mark D Krailo

Mark D Krailo

Publications by authors named "Mark D Krailo"

Are you Mark D Krailo?   Register this Author

68Publications

1533Reads

11Profile Views

A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.

Pediatr Blood Cancer 2019 Feb 30;66(2):e27524. Epub 2018 Oct 30.

Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501793PMC
February 2019

Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group.

Pediatr Blood Cancer 2019 Jan 25;66(1):e27444. Epub 2018 Sep 25.

Center for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249072PMC
January 2019

Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.

J Clin Oncol 2017 Oct 11;35(30):3465-3473. Epub 2017 Sep 11.

Allison F. O'Neill and Christopher B. Weldon, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA; Alexander J. Towbin and Greg M. Tiao, Cincinnati Children's Hospital, Cincinnati, OH; Mark D. Krailo, University of Southern California Keck School of Medicine, Los Angeles; Caihong Xia and Yun Gao, Children's Oncology Group, Monrovia; Marcio Malogolowkin, University of California Davis Comprehensive Cancer Center, Sacramento, CA; M. Beth McCarville, Wayne L. Furman, and Carlos Rodriguez-Galindo, St Jude Children's Research Hospital; Max R. Langham Jr, Le Bonheur Children's Hospital and University of Tennessee, Memphis; Howard M. Katzenstein, Vanderbilt University School of Medicine, Monroe Carell Jr Children's Hospital, Nashville, TN; Rebecka L. Meyers, Primary Children's Hospital and University of Utah, Salt Lake City, UT; Eugene D. McGahren, University of Virginia Children's Hospital and University of Virginia, Charlottesville, VA; Stephen P. Dunn, duPont Hospital for Children and Thomas Jefferson University, Philadelphia; Sarangarajan Ranganathan, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, PA; and Milton J. Finegold, Baylor College of Medicine, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.5654DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648177PMC
October 2017

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.

Neuro Oncol 2016 10 22;18(10):1442-50. Epub 2016 Mar 22.

Departments of Pediatrics (R.I.J.), Pathology (R.L.H.) and Neurosurgery (I.F.P.), University of Pittsburgh School of Medicine, Pittsburgh, PA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland (K.J.C.); Children's Oncology Group, Operations Office, Monrovia, California (A.B., M.D.K.); Department of Preventive Medicine, University of Southern California, Los Angeles, California (M.D.K, S.P.E.); Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (P.C.B.); Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York (M.K.R.); Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia (D.J.B.); Department of Mathematics and Statistics, California State University, Long Beach, California (T.Z.); Maurer Family Cancer Care Center, Bowling Green, Ohio (R.S.L.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035517PMC
October 2016

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.

J Clin Oncol 2016 09 11;34(25):3031-8. Epub 2016 Jul 11.

Joanne P. Lagmay, Shands Hospital for Children, University of Florida, Gainesville, FL; Mark D. Krailo and Ha Dang, University of Southern California, Los Angeles; and Children's Oncology Group, Monrovia; Theodore Zwerdling, Jonathan Jaques Children's Cancer Center, Miller Children's and Women's Hospital, Long Beach, CA; AeRang Kim, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC; Douglas S. Hawkins, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; Orren Beaty III, Zeiss Children's Cancer Center, Mission Hospitals, Asheville, NC; Brigitte C. Widemann, National Institutes of Health Clinical Center, Bethesda, MD; Lisa Bomgaars and Susan M. Blaney, Baylor College of Medicine/Texas Children's Cancer Center, Houston; Anne-Marie Langevin, University of Texas Health Science Center at San Antonio, San Antonio, TX; Holcombe E. Grier and Katherine A. Janeway, Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center, Boston, MA; Brenda Weigel, University of Minnesota, Minneapolis, MN; and Richard Gorlick, The Albert Einstein College of Medicine of Yeshiva University, The Children's Hospital at Montefiore, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.5381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012712PMC
September 2016

Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.

Pediatr Blood Cancer 2016 Feb 16;63(2):370-1. Epub 2015 Sep 16.

Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25754DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830388PMC
February 2016

Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group.

PLoS One 2014 5;9(8):e104378. Epub 2014 Aug 5.

Sarcoma Services, Department of Orthopedic Surgery, University of Utah, Salt Lake City, Utah, United States of America; Center for Children's Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States of America; Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, Utah, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0104378PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122435PMC
November 2015

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.

J Clin Oncol 2015 Sep 24;33(27):3018-28. Epub 2015 Aug 24.

Thomas A. Olson, Emory University, Atlanta, GA; Matthew J. Murray and James C. Nicholson, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom; Carlos Rodriguez-Galindo and A. Lindsay Frazier, Boston Children's Hospital, Boston; Carlos Rodriguez-Galindo, A. Lindsay Frazier, and Christopher Sweeney, Dana-Farber Cancer Institute, Boston, MA; Deborah F. Billmore, Riley Hospital for Sick Children, Indianapolis, IN; Mark D. Krailo and Ha M. Dang, University of Southern California, Los Angeles, CA; James F. Amatruda, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas; David M. Gershenson, University of Texas MD Anderson Cancer Center, Houston, TX; Claire M. Thornton, Royal Victoria Hospital, Belfast, United Kingdom; G. Suren Arul, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom; Sara J. Stoneham, University College London Hospitals NHS Foundation Trust, London, United Kingdom; Farzana Pashankar, Yale University School of Medicine, New Haven, CT; Daniel Stark, University of Leeds, Leeds, United Kingdom; Furqan Shaikh, The Hospital for Sick Children, Toronto; Allan Covens, University of Toronto, Toronto, Ontario, Canada; Jean Hurteau, University of Chicago Pritzker School of Medicine, Chicago, IL; Sally P. Stenning, Medical Research Council, London, United Kingdom; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Peter S. Grimison, Sydney Cancer Center, Sydney, New South Wales, Australia; Robert A. Huddart, Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom; Thomas Powles, Barts Cancer Institute, London, United Kingdom; Luiz Fernando Lopes, Barretos Pediatric Cancer Center, São Paulo, Brazil; Simone dos Santos Agular, Centro Infantil Boldrini, Campinas, Brazil; Girish Chinnaswamy, Tata Memorial Hospital, Mumbai, India; Sahar Khaleel and Sherif Abouelnaga, Children's Cancer Hospital, Cairo, Egypt; and Jul

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.5337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979195PMC
September 2015

Rare Tumors in Children: Progress Through Collaboration.

J Clin Oncol 2015 Sep 24;33(27):3047-54. Epub 2015 Aug 24.

Alberto S. Pappo and Wayne L. Furman, St Jude Children's Research Hospital, Memphis, TN; Kris A. Schultz, Children's Hospital of Minnesota, Minneapolis, MN; Andrea Ferrari, Instituto Nazionale Tumori, Milano, Italy; Lee Helman, National Cancer Institute Center for Cancer Research, Bethesda, MD; and Mark D. Krailo, Keck School of Medicine, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.3632DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979197PMC
September 2015

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

J Clin Oncol 2015 Jul 1;33(20):2279-87. Epub 2015 Jun 1.

Stefan S. Bielack, Klinikum Stuttgart-Olgahospital, Stuttgart; Mathias Werner, Helios Klinikum Emil von Behring; Per-Ulf Tunn, Helios Klinikum Berlin-Buch, Berlin; Knut Helmke, Altonaer Kinderkrankenhaus, Hamburg; Heribert Jürgens, Gabriele Calaminus, Joachim Gerss, and Trude Butterfass-Bahloul, Universitätsklinikum Münster, Münster; Peter Reichardt, Klinik für Interdisziplinäre Onkologie, Bad Saarow, Germany; Sigbjørn Smeland and Kirsten Sundby Hall, Oslo University Hospital; Kirsten Sundby Hall, Norwegian Radium Hospital, Oslo, Norway; Jeremy S. Whelan, University College London Hospitals; Gordana Jovic, Jane M. Hook, and Matthew R. Sydes, University College London; Beatrice Seddon and Maria Michelagnoli, University College Hospital, London; Bernadette Brennan, Christie Hospital and Royal Manchester Children's Hospital, Manchester; Susan Picton, Leeds University Hospital, Leeds, United Kingdom; Neyssa Marina, Stanford University Medical Center; Claudia Deffenbaugh, Lucille Salter Packard Children's Hospital, Palo Alto; Mark D. Krailo, Children's Oncology Group, Arcadia, CA; Mark Gebhardt and Allen Goorin, Dana-Farber Cancer Institute; Mark Gebhardt and Lisa A. Teot, Children's Hospital Boston, Boston, MA; Zsuzsanna Pápai, National Medical Center, Budapest, Hungary; James Meyer, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Helen Nadel, British Columbia Children's Hospital and University of British Columbia, Vancouver, British Columbia; Mark Bernstein, Dalhousie University, Halifax, Nova Scotia, Canada; R. Lor Randall, University of Utah, Salt Lake City, UT; Rajaram Nagarajan, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; G. Douglas Letson, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL; Daniel Baumhoer, Universitätsspital Basel; Thomas Kühne, University Children's Hospital Basel, Basel, Switzerland; Leo Kager, St Anna's Children Hospital; Reinhard Windhager, Medica

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.0734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486345PMC
July 2015

Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group.

Pediatr Blood Cancer 2015 May 2;62(5):759-65. Epub 2014 Dec 2.

Department of Orthopedics, University of Utah, Salt Lake City, Utah; Center for Children's Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376595PMC
May 2015

The Children's Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United States.

Cancer 2014 Oct 29;120(19):3007-15. Epub 2014 May 29.

Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28813DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287245PMC
October 2014

Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: a report from the children's oncology group.

Cancer Epidemiol Biomarkers Prev 2013 Oct 15;22(10):1837-43. Epub 2013 Aug 15.

Authors' Affiliations: The Brown School, Washington University in St. Louis; Department of Pediatrics, School of Medicine, Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri; Division of Epidemiology/Clinical Research, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota; University of Southern California, Los Angeles, California; University of Texas Health Sciences Center San Antonio, San Antonio, Texas; Children's Hospital of Wisconsin, Milwaukee, Wisconsin; and Children's Hospital & Research Center of Oakland, Oakland, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188411PMC
October 2013

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

J Clin Oncol 2012 Nov 22;30(33):4148-54. Epub 2012 Oct 22.

Division of Oncology, CTRB 10, The Children's Hospital of Philadelphia, University of Pennsylvania, 3501 Civic Center Blvd, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.41.5703DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494838PMC
November 2012

Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group.

Cancer 2012 Sep 17;118(18):4597-605. Epub 2012 Jan 17.

Department of Pediatric Hematology-Oncology, Dana-Farber/Children's Hospital Cancer Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008337PMC
September 2012

A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trials.

Contemp Clin Trials 2010 Sep 2;31(5):473-82. Epub 2010 Jun 2.

Rollins School of Public Health, Emory University, Atlanta, GA 30322, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2010.05.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871599PMC
September 2010

Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.

Pediatr Blood Cancer 2009 Oct;53(4):590-3

Department of Pediatrics, Vanderbilt School of Medicine and Vanderbilt Ingram Cancer Center, Nashville, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754403PMC
October 2009

Range and trend of expected toxicity level (ETL) in standard A + B designs: a report from the Children's Oncology Group.

Contemp Clin Trials 2009 Mar 29;30(2):123-8. Epub 2008 Oct 29.

Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2008.10.006DOI Listing
March 2009

Problems identified with phase II stopping rules that employ response and early-progression rates.

J Clin Oncol 2009 Feb 22;27(4):646-7; author reply 647. Epub 2008 Dec 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.9182DOI Listing
February 2009

Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).

J Clin Oncol 2006 Jul;24(21):3423-30

Children's Hospital Los Angeles and the Department Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.9271DOI Listing
July 2006

Fibrolamellar hepatocellular carcinoma in children and adolescents.

Cancer 2003 Apr;97(8):2006-12

Department of Pediatrics, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11292DOI Listing
April 2003

Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.

Clin Cancer Res 2003 Feb;9(2):837-44

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
February 2003

A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.

Neuro Oncol 2003 01;5(1):8-13

Department of Human Oncology, Medical School, University of Wisconsin, 600 Highland Avenue, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1920667PMC
http://dx.doi.org/10.1093/neuonc/5.1.8DOI Listing
January 2003

Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942.

J Pediatr Hematol Oncol 2002 Feb;24(2):89-93

Children's Hospital Research Foundation, Cincinnati, Ohio, USA.

View Article

Download full-text PDF

Source
February 2002